Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2021 filings

All 72 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2021, sourced directly from the official regulator.

72 Filings
2021 Period
2021 filings (72)
Filing Released Lang
Second Price Monitoring Extn
Regulatory Filings
2021-12-30 English
Price Monitoring Extension
Regulatory Filings
2021-12-30 English
Second Price Monitoring Extn
Regulatory Filings
2021-12-29 English
Price Monitoring Extension
Regulatory Filings
2021-12-29 English
Second Price Monitoring Extn
Regulatory Filings
2021-12-16 English
Price Monitoring Extension
Regulatory Filings
2021-12-16 English
Patient Access Expands for Accrufer®
Regulatory Filings
2021-12-16 English
Block Listing 6 Monthly Return
Share Issue/Capital Change
2021-09-30 English
Jose A. Menoyo Appointed as Chief Medical Officer
Board/Management Information
2021-09-27 English
Investor presentation
Report Publication Announcement
2021-09-21 English
PDMR Transaction Notification
Director's Dealing
2021-08-23 English
Half-year Report
Interim / Quarterly Report H1 2021
2021-08-17 English
Licence agreement secured in Republic of Korea
M&A Activity
2021-08-12 English
Notice of Results
Report Publication Announcement
2021-08-11 English
AEGIS-CKD study results published in AJKD
Regulatory Filings
2021-08-09 English
Second Price Monitoring Extn
Regulatory Filings
2021-08-04 English
Price Monitoring Extension
Regulatory Filings
2021-08-04 English
Second Price Monitoring Extn
Regulatory Filings
2021-08-04 English
Price Monitoring Extension
Regulatory Filings
2021-08-04 English
US launch of Accrufer® confirmed for July 1, 2021
Regulatory Filings
2021-06-24 English
Second Price Monitoring Extn
Regulatory Filings
2021-06-23 English
Price Monitoring Extension
Regulatory Filings
2021-06-23 English
Investor presentation
Report Publication Announcement
2021-06-21 English
Directorate Change
Board/Management Information
2021-06-18 English
Results of 2021 Annual General Meeting
AGM Information
2021-06-17 English
Grant of share options to the CEO
Director's Dealing
2021-06-15 English
Appointment of new Chief Executive Officer
Board/Management Information
2021-05-28 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2021-05-28 English
US update
Regulatory Filings
2021-05-21 English
AEGIS-H2H study results published in IBD
Regulatory Filings
2021-05-18 English
Commencement of trading on the OTCQX Best Market
Delisting Announcement
2021-05-17 English
Shield Therapeutics plc Annual report and accounts 2020
Annual Report FY 2020
2021-05-14 English
2020 Annual Report and 2021 AGM Notice
AGM Information
2021-05-13 English
Appointment of Two Non-Executive Directors
Board/Management Information
2021-05-10 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2021-05-06 English
Preliminary Results
Earnings Release FY 2020
2021-04-29 English
Notice of Results
Report Publication Announcement
2021-04-22 English
Holding(s) in Company
Major Shareholding Notification
2021-04-07 English
Holding(s) in Company
Major Shareholding Notification
2021-04-07 English
Second Price Monitoring Extn
Regulatory Filings
2021-04-06 English
Price Monitoring Extension
Regulatory Filings
2021-04-06 English
Holding(s) in Company
Major Shareholding Notification
2021-04-06 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
Block Listing 6 Monthly Return
Regulatory Filings
2021-03-31 English
Investor presentation
Report Publication Announcement
2021-03-30 English
Study demonstrates effectiveness of ferric maltol
Regulatory Filings
2021-03-26 English
Block Listing Application
Share Issue/Capital Change
2021-03-24 English
Holding(s) in Company
Major Shareholding Notification
2021-03-23 English
Holding(s) in Company
Major Shareholding Notification
2021-03-23 English
Shield appoints new Chief Financial Officer
Board/Management Information
2021-03-22 English
Result of General Meeting & Open Offer
Share Issue/Capital Change
2021-03-18 English
Holding(s) in Company
Major Shareholding Notification
2021-03-15 English
Australia's TGA approves Feraccru
Regulatory Filings
2021-03-09 English
PDMR Transaction Notification
Director's Dealing
2021-03-05 English
PDMR/PCA Transaction Notification
Director's Dealing
2021-03-04 English
Investor Presentation
Report Publication Announcement
2021-03-03 English
Publication of Circular and Notice of GM
Proxy Solicitation & Information Statement
2021-03-01 English
Successful completion of £25 million Fundraise
Capital/Financing Update
2021-02-26 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2021-02-26 English
Second Price Monitoring Extn
Regulatory Filings
2021-02-26 English
Price Monitoring Extension
Regulatory Filings
2021-02-26 English
Placing and Subscription to raise up to £25m
Capital/Financing Update
2021-02-26 English
Second Price Monitoring Extn
Regulatory Filings
2021-02-19 English
Price Monitoring Extension
Regulatory Filings
2021-02-19 English
Shareholder loan facilities
Regulatory Filings
2021-01-29 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements
2021-01-29 English
Director/PDMR Shareholding
Director's Dealing
2021-01-21 English
Director/PDMR Shareholding
Director's Dealing
2021-01-19 English
Investor presentation
Regulatory Filings
2021-01-15 English
Business and trading update
Earnings Release FY 2020
2021-01-15 English
Second Price Monitoring Extn
Regulatory Filings
2021-01-14 English
Price Monitoring Extension
Regulatory Filings
2021-01-14 English